Irritable Bowel Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Randomised Controlled Study: Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
Condition: Irritable Bowel Syndrome Intervention: Other: dietary therapy Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2019 Category: Research Source Type: clinical trials
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
Condition: Irritable Bowel Syndrome Intervention: Other: dietary therapy Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2019 Category: Research Source Type: clinical trials
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial
DiscussionThe TRITON trial aims to assess the effect of ondansetron across multiple centres. By defining ondansetron ’s mechanisms of action we hope to better identify patients with IBS-D who are likely to respond.Trial registrationISRCTN,ISRCTN17508514, Registered on 2 October 2017. (Source: Trials)
Source: Trials - August 19, 2019 Category: Research Source Type: clinical trials
Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)
Condition: Irritable Bowel Syndrome With Diarrhea Interventions: Drug: lactobacillus LB; Other: placebo Sponsor: Hospital General de Mexico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2019 Category: Research Source Type: clinical trials
L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults
Condition: Irritable Bowel Syndrome Interventions: Dietary Supplement: L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475; Dietary Supplement: Placebo Sponsors: Innovacion y Desarrollo de Estrategias en Salud; BioGaia AB Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2019 Category: Research Source Type: clinical trials
